<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Korean J Hepatol</journal-id>
      <journal-id journal-id-type="publisher-id">KJHEP</journal-id>
      <journal-title-group>
        <journal-title>The Korean Journal of Hepatology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1738-222X</issn>
      <issn pub-type="epub">2093-8047</issn>
      <publisher>
        <publisher-name>The Korean Association for the Study of the Liver</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21415586</article-id>
      <article-id pub-id-type="pmc">3304613</article-id>
      <article-id pub-id-type="doi">10.3350/kjhep.2010.16.4.405</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A case of hepatocellular carcinoma in the caudate lobe successfully treated by transcatheter arterial chemoembolization using drug-eluting beads</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Joh</surname>
            <given-names>Dong Hoo</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Kim</surname>
            <given-names>Jin Dong</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Young Nam</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Song</surname>
            <given-names>Ha Hun</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Hyun</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Song</surname>
            <given-names>Kyung Ho</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Sang Jin</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Jeong Rok</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jeon</surname>
            <given-names>Won Joong</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cha</surname>
            <given-names>Byung Hyo</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Internal Medicine, Cheju Halla General Hospital, Jeju, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Radiology, Cheju Halla General Hospital, Jeju, Korea.</aff>
      <aff id="A3"><label>3</label>Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: Jin Dong Kim. Department of Internal Medicine, Digestive Disease Center, Cheju Halla General Hospital, #1963-2 Yeon-dong, Jeju 690-766, Korea. Tel. +82-64-740-5082, Fax. +82-64-740-5652, <email>motet76@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>12</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>12</month>
        <year>2010</year>
      </pub-date>
      <volume>16</volume>
      <issue>4</issue>
      <fpage>405</fpage>
      <lpage>409</lpage>
      <history>
        <date date-type="received">
          <day>26</day>
          <month>6</month>
          <year>2010</year>
        </date>
        <date date-type="rev-recd">
          <day>15</day>
          <month>9</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>07</day>
          <month>10</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2010 by The Korean Association for the Study of the Liver</copyright-statement>
        <copyright-year>2010</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Hepatocellular carcinoma (HCC) in the caudate lobe remains one of the most intricate locations where various treatments tend to pose problems with regard to the optimal approach. Surgical resection has been regarded as the most effective treatment; however, isolated resection of the caudate lobe is strenuous and associated with a high rate of early recurrence. Percutaneous ablation might be technically difficult or impossible to perform due to the deep location of tumors and adjacent large vessels. Treatment with drug-eluting beads (DEB) can potentially enhance the therapeutic efficacy for patients with unresectable HCC by drawing on the slower, more consistent drug delivery process. We described a case of a 62-year-old man with HCC in the caudate lobe who was successfully treated by DEB.</p>
      </abstract>
      <kwd-group>
        <kwd>Carcinoma, Hepatocellular</kwd>
        <kwd>Chemoembolization</kwd>
        <kwd>Drug-eluting beads</kwd>
        <kwd>Caudate lobe</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Hepatocellular carcinoma (HCC) is a common tumor with a poor prognosis especially in the hepatitis B endemic country such as Korea. Surgical resection, liver transplantation, and percutaneous ablation are generally accepted as the only curative treatments for HCC.<xref ref-type="bibr" rid="B1">1</xref> Transcatheter arterial chemoembolization (TACE) is the standard first-line treatment for patients with inoperable and intermediate HCC, but response rates and evidence of a survival benefit is relatively low.<xref ref-type="bibr" rid="B2">2</xref> Although there are several therapeutic options for the treatment of HCC, HCC in the caudate lobe is regarded as a clinical hot potato owing to limitation of applicable therapeutic method pertinent to the lesion.</p>
      <p>Recently, drug delivery embolization system, that is drug-eluting beads (DEB), with the ability to sequester chemotherapeutic agent from solution and release it in a sustained and controlled mode were introduced for TACE.<xref ref-type="bibr" rid="B3">3</xref> We described a case of early-staged caudate HCC which was treated completely by TACE using DEB.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 62-year-old man with alcoholic cirrhosis visited outpatient clinic for unexplained weight loss. He had a good performance status (grade 0). Laboratory tests showed serum albumin level of 5.3 g/dL, bilirubin level of 1.3 mg/dL, and prothrombin time international normalized ratio of 1.1. Neither ascites nor hepatic encephalopathy was found, which corresponded with Child-Pugh class A. Serologic markers for hepatitis B and C were negative. Serum &#x3B1;-fetoprotein level was 311.7 ng/mL, and PIVKA-II level was over 2,000 mAU/mL. Other laboratory findings including tumor markers and thyroid function tests were within normal limits. About a 5 cm sized ovoid enhancing mass in arterial phase involving the caudate lobe with underlying cirrhotic configuration of the liver was shown on the dynamic computed tomography (CT) and magnetic resonance imaging (MRI) (<xref ref-type="fig" rid="F1">Fig. 1A-B and 1C-D</xref>, respectively). There was no vascular invasion and no intraabdominal lymphadenopathy. On positron emission tomography-CT, maximum standardized uptake value for the mass was 6.3 without evidence of distant metastasis. Overall, early stage of HCC was assigned according to the Barcelona-Clinic-Liver-Cancer (BCLC) HCC staging system.<xref ref-type="bibr" rid="B1">1</xref></p>
      <p>Surgical resection was recommended for the treatment of the HCC, however, he refused the surgical treatment. TACE using DEB was performed after obtaining written informed consent for the procedure. During the first TACE session, hepatic angiogram revealed a definite hypervascular mass supplied by a small branch of the left hepatic artery without apparent arteriovenous shunt (<xref ref-type="fig" rid="F2">Fig. 2A-B</xref>). After positioning the microcatheter tip at the left hepatic artery close to the tumor-feeding branch, a mixture of DEB (DC Bead&#xAE;, 1 vial of 300~500 &#xB5;m diameter, Biocompatibles, UK) loaded with doxorubicin (50 mg) and contrast agent was infused until the flow through the tumor-feeding artery was slowed down. After the infusion, angiogram showed occluded tumor-feeding branch and no tumor staining (<xref ref-type="fig" rid="F2">Fig. 2C</xref>).</p>
      <p>He had no serious adverse event after embolization except mild abdominal pain that was controlled with oral analgesic (tramadol 50 mg <italic>per os tid</italic>). One-month post-embolization CT (<xref ref-type="fig" rid="F3">Fig. 3A-B</xref>) and six-month post-embolization MRI (<xref ref-type="fig" rid="F4">Fig. 4A-B</xref>) showed complete necrosis without viable portions. Follow-up &#x3B1;-fetoprotein level was 3.89 ng/mL, and PIVKA-II level was 21 mAU/mL. This patient remains in good health without cancer recurrence 6 months after the procedure.</p>
    </sec>
    <sec>
      <title>DISCUSSION</title>
      <p>Although HCC arising in the caudate lobe is no common in clinical setting, it is problematic due to its deep anatomical location and close relationship with major vasculatures. Caudate lobe occupies the space below the hepatic hilum in close proximity to ductal and portal confluences and the proximal hepatic arteries, above the inferior vena cava.<xref ref-type="bibr" rid="B4">4</xref> Frequent invasion of the vessels and frequent formation of tumor thrombi in portal vein and inferior vena cava might contribute to intra- and extrahepatic metastases.<xref ref-type="bibr" rid="B5">5</xref> The limitations in proper therapeutic approach to the lesion is clinically challenging. For these reasons, prognosis of caudate HCC is relatively poor.<xref ref-type="bibr" rid="B5">5</xref></p>
      <p>Surgical resection has been generally regarded as curative method for HCC. Although HCC in caudate lobe is rare, resection would be the most effective treatment and provide long-term survival.<xref ref-type="bibr" rid="B6">6</xref> Recently, improvement in surgical technique enables successful resection of caudate HCC, however, several operative risks and HCC recurrence are still remained problems.<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B10">10</xref> As an alternative treatment modality, radiofrequency ablation was conducted to treat caudate HCC by several methods, i.e. conventional percutaneous, laparoscopy-assisted, or intra-operative approaches.<xref ref-type="bibr" rid="B11">11</xref>-<xref ref-type="bibr" rid="B13">13</xref> But the proximity to major vessels contains potential risk of complication and incomplete ablation related with heat sink effect.</p>
      <p>In this case, patient's stage according to BCLC criteria was early, proposed to be treated effectively by resection, liver transplantation or ablation.<xref ref-type="bibr" rid="B1">1</xref> Although TACE was not suitable as first-line therapy for such an early-staged patient, TACE can be performed in patients at the early stage in whom ablation cannot be performed because of tumor location or medical comorbidities.<xref ref-type="bibr" rid="B1">1</xref> By reason of aforementioned treatment limitations and patient's refusal of surgery TACE using DEB was performed, and as a result, therapeutic response was satisfying without any serious complications.</p>
      <p>DEB are a new soft deformable device of spherical shape composed by a polyvinyl alcohol and a hydrophilic monomer that can be loaded with anthracycline derivatives such as doxorubicin.<xref ref-type="bibr" rid="B14">14</xref> So, drug-loaded beads can be delivered intra-arterially into the tumor and elute the chemotherapeutic effect.<xref ref-type="bibr" rid="B3">3</xref> Previous studies have shown that TACE with DEB results in promising efficacy and low toxicity.<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B17">17</xref> Post-embolization syndrome, cholecystitis, liver abscess, and skin rash were reported as procedure-related complications.<xref ref-type="bibr" rid="B17">17</xref> In recent European multicenter comparative study, 212 patients with Child-Pugh A/B cirrhosis and large and/or multinodular, unresectable HCC (BCLC classification A or B) were randomized to receive either conventional TACE or DEB-TACE. According to the per-protocol analysis, objective response rate in the DEB-TACE group was 52%. In subgroup analysis, patients with more advanced disease-defined as Child-Pugh stage B, Eastern Cooperative Oncology Group performance status 1, bilobular or recurrent disease-had a significantly greater objective response rate (53%) in the DEB-TACE group.<xref ref-type="bibr" rid="B18">18</xref></p>
      <p>We cannot assert the efficacy if the patient underwent conventional TACE instead of DEB-TACE. Terayama et al reported that cumulative local recurrence rate after subsegmental TACE for caudate HCC was very high compared with recurrence rate after subsegmental TACE for HCC in the other segments, and technical success rate of the procedure was relatively low (around 70%).<xref ref-type="bibr" rid="B19">19</xref> In previous study that analyzed explants after pre-transplant conventional TACE, a total or at least subtotal necrosis (&#x2265; 80%) was noted in 30% on the liver explants, and half of the explants showed tumor necrosis less than 50%.<xref ref-type="bibr" rid="B20">20</xref> However, experimental study has shown that complete tumor destruction was observed in the DEB-treated animals sacrificed 7 days after treatment.<xref ref-type="bibr" rid="B3">3</xref> It means that DEB could be a potential curative therapeutic modality for HCC if there is no problem regarding embolization procedures.</p>
      <p>We report a case of caudate HCC successfully treated with DEB-TACE. TACE using this new agent could be an alternative therapy or downstaging method for the caudate HCC patients who are not eligible to conventional treatment including surgical resection.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>The authors have nothing to disclose regarding funding or conflict of interest with respect to this manuscript.</p>
    </ack>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>BCLC</term>
          <def>
            <p>Barcelona-Clinic-Liver-Cancer</p>
          </def>
        </def-item>
        <def-item>
          <term>CT</term>
          <def>
            <p>computed tomography</p>
          </def>
        </def-item>
        <def-item>
          <term>DEB</term>
          <def>
            <p>drug-eluting beads</p>
          </def>
        </def-item>
        <def-item>
          <term>HCC</term>
          <def>
            <p>hepatocellular carcinoma</p>
          </def>
        </def-item>
        <def-item>
          <term>MRI</term>
          <def>
            <p>magnetic resonance imaging</p>
          </def>
        </def-item>
        <def-item>
          <term>TACE</term>
          <def>
            <p>transcatheter arterial chemoembolization</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>El-Serag</surname>
              <given-names>HB</given-names>
            </name>
            <name>
              <surname>Marrero</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Rudolph</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Reddy</surname>
              <given-names>KR</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis and treatment of hepatocellular carcinoma</article-title>
          <source>Gastroenterology</source>
          <year>2008</year>
          <volume>134</volume>
          <fpage>1752</fpage>
          <lpage>1763</lpage>
          <pub-id pub-id-type="pmid">18471552</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Llovet</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Bruix</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival</article-title>
          <source>Hepatology</source>
          <year>2003</year>
          <volume>37</volume>
          <fpage>429</fpage>
          <lpage>442</lpage>
          <pub-id pub-id-type="pmid">12540794</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hong</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Khwaja</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Liapi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Torbenson</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Georgiades</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Geschwind</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer</article-title>
          <source>Clin Cancer Res</source>
          <year>2006</year>
          <volume>12</volume>
          <fpage>2563</fpage>
          <lpage>2567</lpage>
          <pub-id pub-id-type="pmid">16638866</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abdalla</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Vauthey</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Couinaud</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>The caudate lobe of the liver: implications of embryology and anatomy for surgery</article-title>
          <source>Surg Oncol Clin N Am</source>
          <year>2002</year>
          <volume>11</volume>
          <fpage>835</fpage>
          <lpage>848</lpage>
          <pub-id pub-id-type="pmid">12607574</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takayasu</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Muramatsu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Shima</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Moriyama</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Yamada</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical and radiologic features of hepatocellular carcinoma originating in the caudate lobe</article-title>
          <source>Cancer</source>
          <year>1986</year>
          <volume>58</volume>
          <fpage>1557</fpage>
          <lpage>1562</lpage>
          <pub-id pub-id-type="pmid">3017540</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Niu</surname>
              <given-names>WY</given-names>
            </name>
            <name>
              <surname>Kan</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Xie</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>DQ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prognostic factors in the surgical treatment of caudate lobe hepatocellular carcinoma</article-title>
          <source>World J Gastroenterol</source>
          <year>2010</year>
          <volume>16</volume>
          <fpage>1123</fpage>
          <lpage>1128</lpage>
          <pub-id pub-id-type="pmid">20205285</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shimada</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Matsumata</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Maeda</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yanaga</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Taketomi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sugimachi</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Characteristics of hepatocellular carcinoma originating in the caudate lobe</article-title>
          <source>Hepatology</source>
          <year>1994</year>
          <volume>19</volume>
          <fpage>911</fpage>
          <lpage>915</lpage>
          <pub-id pub-id-type="pmid">8138265</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hawkins</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>DeMatteo</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Jarnagin</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Fong</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>D'Angelica</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Caudate hepatectomy for cancer: a single institution experience with 150 patients</article-title>
          <source>J Am Coll Surg</source>
          <year>2005</year>
          <volume>200</volume>
          <fpage>345</fpage>
          <lpage>352</lpage>
          <pub-id pub-id-type="pmid">15737844</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tanaka</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shimada</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shirabe</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Maehara</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tsujita</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Taketomi</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Surgical outcome of patients with hepatocellular carcinoma originating in the caudate lobe</article-title>
          <source>Am J Surg</source>
          <year>2005</year>
          <volume>190</volume>
          <fpage>451</fpage>
          <lpage>455</lpage>
          <pub-id pub-id-type="pmid">16105535</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Utsunomiya</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Okamoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tsujita</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ohta</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tagawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Matsuyama</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>High dorsal resection for recurrent hepatocellular carcinoma originating in the caudate lobe</article-title>
          <source>Surg Today</source>
          <year>2009</year>
          <volume>39</volume>
          <fpage>829</fpage>
          <lpage>832</lpage>
          <pub-id pub-id-type="pmid">19779785</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peng</surname>
              <given-names>ZW</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>JQ</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>YQ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Percutaneous radiofrequency ablation for the treatment of hepatocellular carcinoma in the caudate lobe</article-title>
          <source>Eur J Surg Oncol</source>
          <year>2008</year>
          <volume>34</volume>
          <fpage>166</fpage>
          <lpage>172</lpage>
          <pub-id pub-id-type="pmid">17851020</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ishiko</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Beppu</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sugiyama</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Masuda</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Komori</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Radiofrequency ablation with hand-assisted laparoscopic surgery for the treatment of hepatocellular carcinoma in the caudate lobe</article-title>
          <source>Surg Laparosc Endosc Percutan Tech</source>
          <year>2008</year>
          <volume>18</volume>
          <fpage>272</fpage>
          <lpage>276</lpage>
          <pub-id pub-id-type="pmid">18574414</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>HO</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Son</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Yoo</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>HP</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>YK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach</article-title>
          <source>Hepatobiliary Pancreat Dis Int</source>
          <year>2009</year>
          <volume>8</volume>
          <fpage>591</fpage>
          <lpage>596</lpage>
          <pub-id pub-id-type="pmid">20007075</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lewis</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Gonzalez</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Lloyd</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Willis</surname>
              <given-names>SL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization</article-title>
          <source>J Vasc Interv Radiol</source>
          <year>2006</year>
          <volume>17</volume>
          <fpage>335</fpage>
          <lpage>342</lpage>
          <pub-id pub-id-type="pmid">16517780</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Varela</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Real</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Burrel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Forner</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sala</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Brunet</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics</article-title>
          <source>J Hepatol</source>
          <year>2007</year>
          <volume>46</volume>
          <fpage>474</fpage>
          <lpage>481</lpage>
          <pub-id pub-id-type="pmid">17239480</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Poon</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Tso</surname>
              <given-names>WK</given-names>
            </name>
            <name>
              <surname>Pang</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Woo</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Tai</surname>
              <given-names>KS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead</article-title>
          <source>Clin Gastroenterol Hepatol</source>
          <year>2007</year>
          <volume>5</volume>
          <fpage>1100</fpage>
          <lpage>1108</lpage>
          <pub-id pub-id-type="pmid">17627902</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malagari</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chatzimichael</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Alexopoulou</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kelekis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Dourakis</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients</article-title>
          <source>Cardiovasc Intervent Radiol</source>
          <year>2008</year>
          <volume>31</volume>
          <fpage>269</fpage>
          <lpage>280</lpage>
          <pub-id pub-id-type="pmid">17999110</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lammer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Malagari</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Vogl</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Pilleul</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Denys</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Watkinson</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study</article-title>
          <source>Cardiovasc Intervent Radiol</source>
          <year>2010</year>
          <volume>33</volume>
          <fpage>41</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">19908093</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Terayama</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Miyayama</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tatsu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Toya</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Subsegmental transcatheter arterial embolization for hepatocellular carcinoma in the caudate lobe</article-title>
          <source>J Vasc Interv Radiol</source>
          <year>1998</year>
          <volume>9</volume>
          <fpage>501</fpage>
          <lpage>508</lpage>
          <pub-id pub-id-type="pmid">9618113</pub-id>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Decaens</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Roudot-Thoraval</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bresson-Hadni</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gugenheim</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Durand</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma</article-title>
          <source>Liver Transpl</source>
          <year>2005</year>
          <volume>11</volume>
          <fpage>767</fpage>
          <lpage>775</lpage>
          <pub-id pub-id-type="pmid">15973710</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>An irregularly enhanced mass measuring 5 cm in the caudate lobe with delayed wash-out was observed on dynamic CT (A: arterial phase, B: portal phase, coronal section). Similar signal intensity was noted on MRI (C: T1-weighted image, D: T2-weighted image).</p>
      </caption>
      <graphic xlink:href="kjhep-16-405-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>(A) Celiac arteriography showed a faint hypervascular tumor staining in the caudate lobe supplied by a branch from the left hepatic artery. (B) Selective left hepatic arteriography clearly demonstrated the tumor (arrow heads) and a single supplying artery branch (arrow) from the left hepatic artery. (C) Post-embolization celiac arteriography showed no more tumor staining and occlusion of the tumor supplying artery.</p>
      </caption>
      <graphic xlink:href="kjhep-16-405-g002"/>
    </fig>
    <fig id="F3" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Complete necrosis of a previously noted lesion without remnant or new enhancement was observed (A: arterial phase, B: portal phase).</p>
      </caption>
      <graphic xlink:href="kjhep-16-405-g003"/>
    </fig>
    <fig id="F4" position="float">
      <label>Figure 4</label>
      <caption>
        <p>Regression in the size of the necrotic lesion (3 cm diameter) without definite evidence of recurrence was noted on six-month post-embolization MRI (A: arterial phase, B: delayed phase).</p>
      </caption>
      <graphic xlink:href="kjhep-16-405-g004"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
